QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
Log in
ETR:SAZ

STADA Arzneimittel Aktiengesellschaft (SAZ.F) Stock Forecast, Price & News

€80.40
0.00 (0.00 %)
(As of 11/27/2018)
Add
Compare
Today's Range
€79.56
Now: €80.40
€80.98
50-Day Range
€80.40
MA: €80.40
€80.40
52-Week Range
€53.41
Now: €80.40
€80.98
Volume92,068 shs
Average Volume51,761 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux. The Branded Products segment offers APO-Go a Parkinson's medicine; Grippostad a cold medicine; Aqualor for rhinitis/sore throat; Snup for rhinitis; and Vitaprost for prostate disease indications. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH.
Read More
STADA Arzneimittel Aktiengesellschaft (SAZ.F) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.38 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-6101-6030
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
€80.40
0.00 (0.00 %)
(As of 11/27/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive SAZ News and Ratings via Email

Sign-up to receive the latest news and ratings for SAZ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STADA Arzneimittel Aktiengesellschaft (SAZ.F) (ETR:SAZ) Frequently Asked Questions

What stocks does MarketBeat like better than STADA Arzneimittel Aktiengesellschaft (SAZ.F)?

Wall Street analysts have given STADA Arzneimittel Aktiengesellschaft (SAZ.F) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STADA Arzneimittel Aktiengesellschaft (SAZ.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s key competitors?

What other stocks do shareholders of STADA Arzneimittel Aktiengesellschaft (SAZ.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STADA Arzneimittel Aktiengesellschaft (SAZ.F) investors own include ProSiebenSat.1 Media SE (PSM.F) (PSM), Renault SA (RNO.PA) (RNO), Sarepta Therapeutics (SRPT), VOLKSWAGEN (VLKAY), Volkswagen AG (VOW3.F) (VOW3), ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), The Andersons (ANDE) and ANI Pharmaceuticals (ANIP).

Who are STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s key executives?

STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s management team includes the following people:
  • Mr. Mark Burgess Keatley MBA, MA, MPhil, CFO & Member of Exec. Board (Age 61)
  • Mr. Peter Goldschmidt, Chairman of the Exec. Board & CEO (Age 54)
  • Mr. Miguel Pagan Fernandez, CTO & Member of Exec. Board (Age 53)
  • Mr. Sebastian Kramer-Bach, Exec. VP of Corp. Communication (Age 43)
  • Ms. Kay Reubelt, Director of Investor Relations

What is STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s stock symbol?

STADA Arzneimittel Aktiengesellschaft (SAZ.F) trades on the ETR under the ticker symbol "SAZ."

What is STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s stock price today?

One share of SAZ stock can currently be purchased for approximately €80.40.

What is STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s official website?

The official website for STADA Arzneimittel Aktiengesellschaft (SAZ.F) is www.stada.de.

How can I contact STADA Arzneimittel Aktiengesellschaft (SAZ.F)?

STADA Arzneimittel Aktiengesellschaft (SAZ.F)'s mailing address is Stadastrasse 2-18, BAD VILBEL, 61118, Germany. The company can be reached via phone at +49-6101-6030.

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.